Indocyanine Green (ICG) and SPY Imaging for Assessment of Burn Healing

Predictors of Burn Wound Healing Clinical Trial

Official title: Use of Indocyanine Green (ICG) Fluorescence as a Noninvasive Means to Assess Burn Wound Severity and Healing

Status Completed

Clinical Trial Summary

Hypothesis: Higher levels of perfusion on indocyanine green (ICG) fluoroscopy indicate higher likelihood of burns healing whole lower levels of perfusion correlate with lower likelihood of healing

Consented patients with burn injuries will be evaluated daily and along with continued wound care will receive 5 mg of ICG (FDA approved dose) and their burns assessed fluoroscopically. Perfusion will be quantified numerically as a percentage of normally perfused skin. No changes to the actual care of the burn patient will be made as a result of the fluoroscopic examination.

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Burns
• Predictors of Burn Wound Healing

• NCT number: NCT02028520
• Study type: Interventional
• Source: Texas Tech University Health Sciences Center
• Status: Completed
• Phase: N/A
• Start date: January 2014
• Completion date: August 2014